Meliha Brankov

889 total citations
17 papers, 713 citations indexed

About

Meliha Brankov is a scholar working on Molecular Biology, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Meliha Brankov has authored 17 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Ophthalmology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Meliha Brankov's work include Retinal Development and Disorders (12 papers), Retinal and Optic Conditions (7 papers) and Retinal Diseases and Treatments (5 papers). Meliha Brankov is often cited by papers focused on Retinal Development and Disorders (12 papers), Retinal and Optic Conditions (7 papers) and Retinal Diseases and Treatments (5 papers). Meliha Brankov collaborates with scholars based in Australia, United States and India. Meliha Brankov's co-authors include P. Elizabeth Rakoczy, Chooi‐May Lai, Ian J. Constable, Robert J. Marano, István Tóth, Norbert Wimmer, Nigel L. Barnett, Yvonne K. Y. Lai, Piroska E. Rakoczy and Elizabeth Rakoczy and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and Investigative Ophthalmology & Visual Science.

In The Last Decade

Meliha Brankov

17 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meliha Brankov Australia 10 554 336 240 117 52 17 713
Thiago Cabral Brazil 15 381 0.7× 347 1.0× 178 0.7× 60 0.5× 7 0.1× 35 657
Elodie Touchard France 13 305 0.6× 225 0.7× 125 0.5× 53 0.5× 6 0.1× 17 521
Richard M. Comer United Kingdom 11 179 0.3× 133 0.4× 228 0.9× 108 0.9× 37 0.7× 12 470
Miguel Jarrı́n United Kingdom 11 313 0.6× 106 0.3× 148 0.6× 25 0.2× 8 0.2× 20 563
Joke Devoldere Belgium 9 366 0.7× 171 0.5× 148 0.6× 69 0.6× 2 0.0× 12 553
B. Thillaye–Goldenberg France 18 248 0.4× 389 1.2× 105 0.4× 77 0.7× 2 0.0× 21 716
B.K. Ambati United States 8 156 0.3× 119 0.4× 216 0.9× 18 0.2× 3 0.1× 14 436
Ninfa G. Lopez United States 10 462 0.8× 29 0.1× 75 0.3× 36 0.3× 6 0.1× 11 603
Sanja Turturro United States 8 193 0.3× 64 0.2× 49 0.2× 14 0.1× 6 0.1× 9 370
Ding-Wen Chen Canada 10 285 0.5× 46 0.1× 24 0.1× 83 0.7× 6 0.1× 18 394

Countries citing papers authored by Meliha Brankov

Since Specialization
Citations

This map shows the geographic impact of Meliha Brankov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meliha Brankov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meliha Brankov more than expected).

Fields of papers citing papers by Meliha Brankov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meliha Brankov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meliha Brankov. The network helps show where Meliha Brankov may publish in the future.

Co-authorship network of co-authors of Meliha Brankov

This figure shows the co-authorship network connecting the top 25 collaborators of Meliha Brankov. A scholar is included among the top collaborators of Meliha Brankov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meliha Brankov. Meliha Brankov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lai, Chooi‐May, Marie J. Estcourt, Matthew E. Wikström, et al.. (2009). rAAV.sFlt-1 Gene Therapy Achieves Lasting Reversal of Retinal Neovascularization in the Absence of a Strong Immune Response to the Viral Vector. Investigative Ophthalmology & Visual Science. 50(9). 4279–4279. 33 indexed citations
2.
Rakoczy, Elizabeth, et al.. (2006). 418. AAV-Mediated sFLT-1 Gene Therapy for Ocular Neovascularization: Longevity, Toxicity and Efficacy Results from Mice and Monkeys. Molecular Therapy. 13. S160–S161. 1 indexed citations
3.
Marano, Robert J., István Tóth, Norbert Wimmer, Meliha Brankov, & P. Elizabeth Rakoczy. (2005). Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity. Gene Therapy. 12(21). 1544–1550. 121 indexed citations
4.
Lai, Chooi‐May, Meliha Brankov, Yvonne K. Y. Lai, et al.. (2005). Long-term Evaluation of AAV-Mediated sFlt-1 Gene Therapy for Ocular Neovascularization in Mice and Monkeys. Molecular Therapy. 12(4). 659–668. 97 indexed citations
5.
Zhang, Dan, Meliha Brankov, Terry Robertson, et al.. (2005). Correlation between Inactive Cathepsin D Expression and Retinal Changes inmcd2/mcd2Transgenic Mice. Investigative Ophthalmology & Visual Science. 46(9). 3031–3031. 18 indexed citations
6.
Marano, Robert J., Meliha Brankov, & P. Elizabeth Rakoczy. (2004). Discovery of a Novel Control Element within the 5′-Untranslated Region of the Vascular Endothelial Growth Factor. Journal of Biological Chemistry. 279(36). 37808–37814. 3 indexed citations
7.
Marano, Robert J., Norbert Wimmer, Philip Kearns, et al.. (2004). Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide. Experimental Eye Research. 79(4). 525–535. 66 indexed citations
8.
Lai, Chooi‐May, Meliha Brankov, Nigel L. Barnett, et al.. (2004). Recombinant adeno-associated virus type 2-mediated gene delivery into the Rpe65 -/- knockout mouse eye results in limited rescue. UWA Profiles and Research Repository (UWA). 2(1). 84 indexed citations
9.
Brankov, Meliha, et al.. (2003). Cathepsin D Mutations Associated with Retinal Dystrophy in Transgenic Mice. Investigative Ophthalmology & Visual Science. 44(13). 1702–1702. 1 indexed citations
10.
Marano, Robert J., Norbert Wimmer, Philip Kearns, et al.. (2003). Use of Synthetic Dendrimer Peptide’s to Mediate the Delivery of a Sense Oligonucleotide. Investigative Ophthalmology & Visual Science. 44(13). 1078–1078. 1 indexed citations
11.
Lai, Yvonne K. Y., Shiwani Sharma, Chooi‐May Lai, et al.. (2003). Virus-Mediated Secretion Gene Therapy — A Potential Treatment for Ocular Neovascularization. Advances in experimental medicine and biology. 533. 447–453. 5 indexed citations
12.
Rakoczy, P. Elizabeth, Chooi‐May Lai, Meliha Brankov, et al.. (2003). Assessment of rAAV-Mediated Gene Therapy in the Rpe65-/- Mouse. Advances in experimental medicine and biology. 533. 431–438. 7 indexed citations
13.
Rakoczy, P. Elizabeth, et al.. (2003). Enhanced Recombinant Adeno-Associated Virus-Mediated Vascular Endothelial Growth Factor Expression in the Adult Mouse Retina. Diabetes. 52(3). 857–863. 28 indexed citations
14.
Lai, Chooi‐May, et al.. (2002). Inhibition of Corneal Neovascularization by Recombinant Adenovirus Mediated Antisense VEGF RNA. Experimental Eye Research. 75(6). 625–634. 57 indexed citations
15.
Barry, Christopher J., et al.. (2002). Simple modifications of clinical fundus cameras for retinal photography and angiography in small laboratory animals. UWA Profiles and Research Repository (University of Western Australia). 24(2). 66–69. 1 indexed citations
16.
Brankov, Meliha, et al.. (2002). Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy. Gene Therapy. 9(12). 804–813. 102 indexed citations
17.
Lai, Chooi‐May, Meliha Brankov, Yvonne K. Y. Lai, et al.. (2001). Inhibition of Angiogenesis by Adenovirus-Mediated sFlt-1 Expression in a Rat Model of Corneal Neovascularization. Human Gene Therapy. 12(10). 1299–1310. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thiago Cabral Breakdown of academic impact, for papers by Elodie Touchard Breakdown of academic impact, for papers by Richard M. Comer Breakdown of academic impact, for papers by Miguel Jarrı́n Breakdown of academic impact, for papers by Joke Devoldere Breakdown of academic impact, for papers by B. Thillaye–Goldenberg Breakdown of academic impact, for papers by B.K. Ambati Breakdown of academic impact, for papers by Ninfa G. Lopez Breakdown of academic impact, for papers by Sanja Turturro Breakdown of academic impact, for papers by Ding-Wen Chen
Rankless by CCL
2026